Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of GWZ002 granules for acute exacerbation of chronic obstructive pulmonary disease
CTR20261162Phase 2Active
- Sponsor
- Henan University of Chinese Medicine
- Start
- May 2026
- Countries
- 1
01
Overview
A Phase 2 trial of GWZ002 in chronic obstructive pulmonary disease (COPD), sponsored by Henan University of Chinese Medicine. Started May 2026; status: active.
02
Drugs
GWZ002
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20261162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261162.